Bleakley Financial Group, LLC

Position in ABBV — AbbVie Inc.

CIK 1936953 PARSIPPANY, NJ

Position in ABBV

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$23,178,308

+$7,400,931 QoQ

Shares Held

92,109

+27.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.59%

of 13F equity value

Holder Rank

#562

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Bleakley Financial Group, LLC holds $192,517,114 across 15 Drug Manufacturers - General names. ABBV ranks #3 (12.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	45,004	$53,979,152
2	JNJ	Johnson & Johnson	142,327	$36,146,788
3	ABBV	AbbVie Inc. This page	92,109	$23,178,308
4	MRK	Merck & Co., Inc.	155,898	$20,032,893
5	AMGN	Amgen Inc	38,445	$13,921,703
6	AZN	Astrazeneca PLC	66,437	$12,597,783
7	NVS	Novartis AG	44,930	$7,041,429
8	SNY	Sanofi	159,361	$6,798,340

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,178,308	92,109	+27.0%	Shares	Sole	2026-08-05
2026-03-31	$15,777,377	72,543	-3.8%	Shares	Sole	2026-05-04
2025-12-31	$17,231,344	75,414	+7.7%	Shares	Sole	2026-02-09
2025-09-30	$16,218,682	70,047	+4.3%	Shares	Sole	2025-11-10
2025-06-30	$12,464,383	67,150	+0.8%	Shares	Sole	2025-07-30
2025-03-31	$13,957,384	66,616	+11.6%	Shares	Sole	2025-05-01
2024-12-31	$10,605,491	59,682	+19.8%	Shares	Sole	2025-01-27
2024-09-30	$9,835,096	49,803	-58.6%	Shares	Sole	2024-10-16
2024-06-30	$20,636,771	120,317	+2.4%	Shares	Sole	2024-08-12
2024-03-31	$21,404,216	117,541	+5.5%	Shares	Sole	2024-05-08
2023-12-31	$17,261,023	111,383	-0.5%	Shares	Sole	2024-01-25
2023-09-30	$16,684,583	111,932	+11.3%	Shares	Sole	2023-11-14
2023-06-30	$13,550,739	100,577	+15.1%	Shares	Sole	2023-08-14
2023-03-31	$13,930,531	87,410	-22.9%	Shares	Sole	2023-05-12
2022-12-31	$18,319,301	113,355	—	Shares	Sole	2023-02-07
No filing history on record for this holder in this stock.